chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swelling and redness to the injection site; Small bumps, like a rash on the swollen area; Small bumps, like a rash on the swollen area; swelling and redness to the injection site; this one burned when it was injected; this one burned when it was injected; This is a spontaneous report from a contactable consumer reported for herself. This 32-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EP7533) via an unspecified route of administration in the left arm at 32 years old on 01Apr2021 between 14: 30 and 15: 00 at single dose  for COVID-19 immunization. Medical history included ongoing Eczema for her whole life. Concomitant medications were unknown. The patient had no prior vaccinations (within 4 weeks). The patient previously received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6206) via an unspecified route of administration (injection) in the right arm at 32 years old on 09Mar2021 at single dose  for COVID-19 immunization, experiencing redness at injection site and pain and soreness at injection site. With her second vaccine on 01 Apr 2021 she stated it was different than the first one. This one burned when it was injected. She had swelling and redness to the injection site. The swelling got worse and the redness got darker and more purple. She then developed small bumps, like a rash, to the swollen area. She went to an urgent care on 07 Apr 2021 and they gave her Benadryl and Cortisone, which was helping. She had been taking these for about a week and a half per her report. The patient stated these symptoms were improving but were not all the way gone yet. Outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Patient with known high exposure to monkeypox on 6/16/22. As patient without fever or rash, decision to vaccinate when vaccine available on 6/27/22. On 6/28/22, patient developed lesions on body and groin. Presumed due to development of disease rather than side effect of vaccine. Sent to ER where lesion tested and results pending.
Wednesday about midnight I began coughing/Did not think of COVID/Thursday, I tested positive; Wednesday about midnight I began coughing/Did not think of COVID/Thursday, I tested positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 24Aug2023, outcome "unknown" and all described as "Wednesday about midnight I began coughing/Did not think of COVID/Thursday, I tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Aug2023) Positive, notes: Thursday I tested positive. Clinical course: It was stated that just over COVID. Had all vaccines (Pfizer) & have still wear masks out but not at doctors. It was stated that, "I was at doctors and removed my mask - always did there. Soon, I realized she was sick. I asked & she said yes. She was not wearing mask. Not sure why I did not put mine back on. This was a Monday at 1 pm & Wednesday about midnight I began coughing. Did not think of COVID. Thursday, I tested positive. Could I get it that fast? Doctor tested negative on Tuesday. I do not go out often. Checked with other contacts. No COVID".  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Pt complaining of painful blisters on her leg, ankle, 1-2 wks after receiving the shingles shot. Pt is now seen by Allergist to find out about cause of the blisters. Pt believes the blisters came from shingles shot.
I saw the patient in the emergency department 4 days after she received the 2nd dose of one of the COVID vaccines. I am not sure where she got the vaccine or the manufacturer. She was diagnosed with pericarditis, and this is the reason for this report. She was seen and will be followed by a cardiologist.
half of the vaccine pushed out around the needle (the needle was not tight on the syringe); A spontaneous report was received from a healthcare professional concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and half of the vaccine pushed out around the needle (the needle was not tight on the syringe) (Incorrect dose administered).  The patient's medical history was not provided. Concomitant product use was not provided.   On an unknown date, the patient received their first of two planned doses of mRNA-1273 (LOT # unknown) for prophylaxis of COVID-19 infection.   On an unknown date, during a drive through COVID vaccine event, after injecting the arm and pushing the plunger, about half of the vaccine pushed out around the needle (the needle was not tight on the syringe). No treatment information was provided.    Action taken with the mRNA-1273 in response to the event was not reported.     The event, half of the vaccine pushed out around the needle (the needle was not tight on the syringe) was considered recovered on an unknown date.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273.  There were no reported adverse events associated with this case.
pain in arm; This is a spontaneous report from a contactable consumer (patient's cousin). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date in Dec2020 at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient previously took aspirin and was allergic to it. The consumer stated that the patient was administered the new COVID19 Vaccine a few days prior to the report and she experienced pain in arm in Dec2020 that lasted for 2 days. The outcome of the event was recovered in Dec2020.  Information on the lot/batch number has been requested.
Four hours after injection- headache that hasn?t gone away even with Tylenol  Eight hours after injection-chills that lasted for Two hours. Eight hours after injection- body aches that haven?t gone away yet even with Tylenol Eight hours after injection- joint stiffness that lasted two hours  Eight hours after injection- a little bit of fatigue  Using 2 extra strength Tylenol every four hours
Received an expired dose of the Moderna COVID19; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received an expired dose of the Moderna COVID19) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received an expired dose of the Moderna COVID19). On 30-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received an expired dose of the Moderna COVID19) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were mentioned.  No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Follow up received contain reporter's details updated and patient's initial, date of birth and gender has been updated.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients with unknown ages and genders. On an unknown date the patients were vaccinated with ZOSTAVAX, subcutaneous (lot #, expiry date, dose unknown). The pharmacist reported that he received a phone call from a physician's office in which a medical assistant was administering with ZOSTAVAX and telling patients to rub the injection site. These unspecified number of patients were reporting that they were experiencing more irritation at the injection site after they rubbed the area. No treatment was given for the event. The outcome of the event was unknown. Additional information has been requested.
Rash in her armpit; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in her armpit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash in her armpit). At the time of the report, RASH (Rash in her armpit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2021-098177 (Patient Link).
My son first developed cough for two days, then abdominal pain for one day followed by nausea for one day.  On 12/2/09, he developed headaches and fever and intermittent leg tingling.  Cough has always persisted then fever continued until he was diagnosed with pneumonia on 12/5/09.
shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was reported.   This case was linked to MOD-2022-468520, MOD-2022-468516 (Patient Link).
Patient reports having a 3x3" area of redness, swelling, hot to the touch starting 1/2" below injection site. She states that the day following the injection he had headache, diarrhea. She says that now the area where injected is itchy and blistered.
approximately 24 hours post vaccine fainted. pt's partner describes he was walking toward her and then suddenly fell to the ground "passed out cold"  She tried to talk to him and at first he did not make sense but after few minutes was able to converse.  Call to pharmacy was made about 3 hours after event and pt has recovered, main complaints were weakness and sore (bruised himself when falling).
Woke up at 12:30 am feeling hot.  couldn't sleep.    At 3am took Advil 200mg. Fever at 8am = 99.5.
FLUSHING, SWEATING, COLDNESS OF SKIN, DIZZINESS, CHEST DISCOMFORT, LOWER BACK PAIN.
Mild upper arm pain within 3 hours of shot; extreme arm pain and stiffness following morning. 24 hours post shot, severe chills and low grade fever.
large local rxn w/fever;10NOV94 f/u large red welt lasted approx 1 w/fever 100;no treatment, mom wanted to wait it out
Patient was not of qualified age when give the COVID 19 vaccine.  Patient was 15 years old at time of vaccine administration. Patient did not experience any adverse events during observation period nor did patient report any symptoms post vaccine.
On 6-3-98 pt recv vax; on 6-5-98 pt exp a baseball size welt on thigh at the injection site.  Pt to be seen by Dr 6-5-98.
she got a rash on her face; This is a spontaneous report from via a contactable consumer (patient) reported for herself. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to report a reaction from the first dose of COVID-19 vaccine. On an unspecified date, the patient got a rash on her face a week after first dose. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient experienced arm pain from the injection site down to the lower arm and under the armpit to the point where she could not sleep on that side.
I had a heart attack or major cardiac stress event after receiving the vaccine . This is concerning because when they did all of their imaging and test my heart is in perfect condition and there are no blockages and there was no reason for this to happen. After the vaccine I was fighting massive fatigue and muscle cramps. In the hospital ran my labs and found out that my potassium had bottomed out to critical level and is very likely the cause of this. But why did the vaccine cause my potassium to bottom out?? I eat healthy and take potassium supplements. I?ve been weight training and competing in bodybuilding and powerlifting competitions for about a decade. So having a healthy diet and understanding nutrition is something that I understand a lot more than the average person.
This case was reported by a physician and described the occurrence of chills in a male patient who received Flue Seasonal TIV Dresden (influenza vaccine). Concomitant products included LATUDAY and KLONOPIN.  In October 2014, the patient received influenza vaccine. In October 2014, 1 day after receiving influenza vaccine, the patient experienced chills and feels ing cold. On an unknown date, the outcome of the chills and feeling cold were recovered/resolved. The reporter considered the chills and feeling cold to be probably related to influenza vaccine.  Additional information received: Male patient of unknown age who experienced the chills and feeling cold while receiving treatment with Latuda. In October 2014, the patient initiated treatment with   Latuda 20 mg every evening with flood (indication for use not provided) and after the second dose experienced the chills and feeling cold for a duration of four hours from 04:30-08:30. The patient indicated he had the flue shot the day before he experienced the events. Concomitant medications included Klonopin while medical history was not provided. The flu shot was considered co-suspect for the events as the physician indicated that the chills may have been from the flu shot. At the time of the report, the action taken with Latuda was unknown while the outcome of the events was considered resolved after four hours. The physician was not able to determine if the events were related to Latuda.
Increased heart resting rate to between 101 and 104. Minor walking to another room would increase  heart rate to 130-140. This lasted for a few hours.
Dec 18th severe headache, no medication administered due to patient's dislike of taking pills. SEVERE headache with right side eye pain, vomitting and fever continued until 12/21 .. when I took him to the ER ..  no confusion or change in mental ability presented in days prior. In ER slurred speech along with mental state changed drastically. Confusion, delirium, physical stability to walk or sustain own weight wasn't possible. Sedation was given to calm patients aggravation.  CT confirmed Intracranial hemorrhage on the right side between occipital and temporal lobe. Patient was intubated and air lifted to larger hospital.  In transit had a seizure.
On approximately October 12, after receiving the Gardasil 9 vaccine on September 30, I noticed that my "sore" left arm was not just sore but had a nodule in the tissue. I measured the nodule, and it was about 2 cm in diameter. I applied heat and massaged it, but it did not help. I messaged my provider's office on October 18 to ask if this was abnormal and if I should do anything else. My provider replied that I should continue to apply heat and that this was normal. I did apply heat as often as possible, and I even slept with heat for several hours at a time. This did not seem to speed up the resolution of the nodule. The nodule increased in size to 3 cm and swelled up to a round knot. I would say that it was 3 cm diameter by the end of October and increasingly sore and heavy. It gradually decreased in size in the latter half of November. Today I have no nodule but my left arm is still slightly sore. I still do not feel that I could receive another vaccine in the left arm without anxiety because of the soreness.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Nov2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 32 years for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures (Paxlovid) were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300279897 same reporter/patient, different drug/event;
11/26/2020-11/28/2020, bloody stools throughout the day. Bloody stools did not continue on and after 11/29/2020. Follow-up phone call with Nurse Practitioner;medical test ordered for colonoscopy and blood work to be scheduled.
Within a minute after vaccine administered patient was observed developing diffuse erythema of her arms and face with urticarial lesions, complained of throat tightness and numbness/paresthesias of her R arm. Within a minute no longer complaining of throat tightness and within several minutes numbness/paresthesias resolved. Vital signs stable except tachycardia (HR 136->125). Given BENADRYL and transferred by EMS to local emergency room for further management.
Employee had 104.7 temp, chills, vomited x7, heart rate 137/min, lethargic
I had an reaction to the first dose of covid-19 vaccine. Within minutes I thought I was going to pass out. 3 days after the vaccine I noticed a lump with pain in my forearm. I suspected a blood clot in my forearm. I had a confirm ultrasound of a DVT in my right upper extremity brachial veins.
Inappropriate Schedule of Vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a 50-year-old female patient who received HBV (Engerix B adult) (batch number NT9X3, expiry date 09-SEP-2024) for prophylaxis.   Previously administered products included Engerix B adult (1st dose received on 28th June 2023).   On 13-SEP-2023, the patient received the 2nd dose of Engerix B adult. On 13-SEP-2023, an unknown time after receiving Engerix B adult, the patient experienced drug dose administration interval too long (Verbatim: Inappropriate Schedule of Vaccine). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-SEP-2022 The patient received 2nd dose of Engerix B adult, later than the recommended interval, which led to lengthening of vaccination schedule. The reporter consented to follow up.
Evening of vaccination, states that she noticed she was continually clearing her throat. Throat felt "sore, scratchy, and on fire." Stated sternum was sore, and hurt to breathe. Stated she called local ER and was advised to just take tylenol and benadryl, and go to bed. States when she woke up this morning, "eyes were glued shut", still has sensation of "lump in throat, and it feels full of phlegm." Does state that she feels better this morning than she did last night.
Rash, itching, bumps (elevated and raised). MD advised treatment with Benadryl all symptoms disappeared after medication taken.
This spontaneous report as received from a public health, healthcare professional refers to unspecified patients of unknown age and gender. On an unknown date the unspecified patients might had vaccinated with improperly stored M-M-R II (lot#, dose, frequency and route unspecified), which were exposed to 53F for 12 hours and M-M-R II (lot#, dose, frequency and route unspecified), which were exposed to 54F for five hours. No adverse effects reported. Follow up information has been received from an office manager concerning a patient. On 23-OCT-2013 the patient was vaccinated with improperly stored M-M- R II (J003791, exp. 28-MAR-2015), which were exposed to 53F for 12 hours (date excursion ended 22-JUL-2013). This is one of several reports received from the same source (linked MARRS#: 1311USA007619, 1311USA011609, 1311USA011610, 1311USA011611, 1311USA011612, 1311USA011614, 1311USA011615, 1311USA011616, 1311USA011617, 1311USA011618, 1311USA011619). Additional information is not expected.
arthritis; pain in hands;pain in feet; swelling in hands;swelling in feet; This spontaneous report was received from a female patient of unknown age who is a medical assistant, regarding herself. Patient's concurrent conditions and relevant medical history was not reported. On 17-JUN-2014 the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 0.5 milliliter once (lot number, expiration date and route of administration were not provided) administered for prophylaxis. Concomitant medications were not reported. On an unknown date in 2014, after vaccination with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), the patient experienced pain and swelling in elbows, feet, hands and shoulders. The outcome of the events was reported as not recovered/not resolved. The causality of the events with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not reported. All the data provided was reconfirmed by the reporter.  Follow-up information has been received from the medical assistant (consumer) on 21-NOV-2022. On an unknown date in 2014 (reported as about 2 and a half weeks after vaccination), the patient developed arthritis and arthralgia that lasted for 2 years. The patient stated she reported these symptoms to her doctor, but he was concerned and did not want to prescribe steroids since it was a result of a vaccination. The outcome of the events was unknown. The causality of the events with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was reported as related. The reporter considered arthritis and arthralgia to be disability.; Sender's Comments: , MERCK1411USA001395:Mfr number
From 10-pm to 4 am fever, chills, face and hand swelling, extreme body aches, insomnia, dizziness all joints sharply painful from neck to toes on flexion
Fever to 103F, 6 days after MMR. Few red spots on trunk developed 8 days after MMR. Fever lasted 24 hours. Rash persisting X 3 days.